FDA – Page 62 – Policy & Medicine

FDA Staff Disagreements May Be Cause of Delays in Implementation of PDUFA

FDA Draft Guidance on Safety Labeling Changes

Senate Special Committee on Aging: FDA and the Reform of the Medical Device Approval Process

The Scope of Jurisdiction of DDMAC with Pharmaceutical and Device Manufactures

FDA Guidance for Industry Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies

FDA Webinar How to Report Your Local Sales Rep

FDA Regulations Doubles Review Time and Quadruples Trial Size for Diabetes Therapies

FDA Budget: Trying to Do Everything on Less Money

FDA Medical Device Innovation Initiative

FDA Guidance: Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination